Treatment of Temporo-Myofascial Disorder of Muscular Origin Using Botulinum Toxin: A Prospective Study

NCT02810015 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Temporo-Myofascial Disorder

Interventions

DRUG: Botulinum Toxin Type A

Sponsor

University of Manitoba